The immune systems of cancer patients may play a significant role in their treatment outcomes, according to a study on Tuesd ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Introduction: A unique feature of chronic lymphocytic leukemia (CLL) is the increased number of circulating T cells preventing malignant B cells from undergoing apoptosis. Dysregulated expression of ...

It involves an infusion of white blood cells, called lymphocytes, from the donor of the stem cell transplant into the patient. DLI is successful in only about 15-20% of patients with AML.

Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia in the United States. Leukemia is a group of cancers that develop in blood cells. CLL develops in a type of white blood ...

It involves an infusion of white blood cells, called lymphocytes, from the donor of the stem cell transplant into the patient. DLI is successful in only about 15-20% of patients with AML.

It is the first comprehensive cellular analysis of ALS, carried out using single-cell RNA sequencing in 14 patients and 14 ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

Pfizer’s Takeda-partnered blood cancer drug Adcetris (brentuximab vedotin) has been approved by the US Food and Drug ...